GENCARO BUCINDOLOL HCL Trademark

Trademark Overview

On Wednesday, May 6, 2009, a trademark application was filed for GENCARO BUCINDOLOL HCL with the United States Patent and Trademark Office. The USPTO has given the GENCARO BUCINDOLOL HCL trademark a serial number of 77730838. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 4, 2013. This trademark is owned by Arca biopharma, Inc.. The GENCARO BUCINDOLOL HCL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of diseases and disorders in the cardiovascular, vascular and hematology fields
gencaro bucindolol hcl

General Information

Serial Number77730838
Word MarkGENCARO BUCINDOLOL HCL
Filing DateWednesday, May 6, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 4, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 10, 2009

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BUCINDOLOL HCL"
Description of MarkThe mark consists of an image of heart with the words "Gencaro Bucindolol HCl" to the right.
Goods and ServicesPharmaceutical preparations for use in the treatment of diseases and disorders in the cardiovascular, vascular and hematology fields
Lining/Stippling StatementThe stippling is for shading purposes only.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 11, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArca biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBroomfield, CO 80021
Party NameArca biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBroomfield, CO 80021

Trademark Events

Event DateEvent Description
Monday, March 4, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 4, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 8, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 7, 2012EXTENSION 5 GRANTED
Thursday, August 2, 2012EXTENSION 5 FILED
Thursday, August 2, 2012TEAS EXTENSION RECEIVED
Wednesday, February 8, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2012EXTENSION 4 GRANTED
Thursday, February 2, 2012EXTENSION 4 FILED
Thursday, February 2, 2012TEAS EXTENSION RECEIVED
Thursday, September 29, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 28, 2011TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, August 2, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 1, 2011EXTENSION 3 GRANTED
Wednesday, July 27, 2011EXTENSION 3 FILED
Wednesday, July 27, 2011TEAS EXTENSION RECEIVED
Saturday, February 19, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 18, 2011EXTENSION 2 GRANTED
Wednesday, February 2, 2011EXTENSION 2 FILED
Friday, February 18, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 2, 2011TEAS EXTENSION RECEIVED
Saturday, June 26, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 24, 2010EXTENSION 1 GRANTED
Thursday, June 24, 2010EXTENSION 1 FILED
Thursday, June 24, 2010TEAS EXTENSION RECEIVED
Tuesday, February 2, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 6, 2010TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 10, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2009PUBLISHED FOR OPPOSITION
Friday, October 2, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 25, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 22, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, September 22, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 22, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, September 22, 2009EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 2, 2009EXAMINER'S AMENDMENT ENTERED
Wednesday, September 2, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 2, 2009EXAMINERS AMENDMENT E-MAILED
Wednesday, September 2, 2009EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 11, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 11, 2009ASSIGNED TO LIE
Friday, July 24, 2009PAPER RECEIVED
Wednesday, July 22, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 22, 2009NON-FINAL ACTION E-MAILED
Wednesday, July 22, 2009NON-FINAL ACTION WRITTEN
Wednesday, July 15, 2009ASSIGNED TO EXAMINER
Tuesday, May 12, 2009NOTICE OF DESIGN SEARCH CODE MAILED
Monday, May 11, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 9, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

bucindolol gencaro vascular hematology fields cardiovascular disorders preparations treatment diseases pharmaceutical